Communiqués Novogenia AG Deutsche Boerse AG

Actions

Marché Fermé - Deutsche Boerse AG Autres places de cotation 08:01:37 24/07/2026			Varia. 5j.	Varia. 1 janv.
6,350 ^EUR	-4,51%		+11,40%	-19,11%

20/07	Novogenia lance la construction de son nouveau siège social en Autriche	MT
20/07	Novogenia AG investit dans les technologies de santé et de production sur son nouveau siège de Hallwang	CI

20/07	Novogenia AG Invests in State-of-the-Art Healthcare and Manufacturing Technologies at Its New Hallwang Headquarters	EQ
15/07	Darwin AG becomes Novogenia AG, strengthening its international position	EQ
26/06	Darwin AG Announces Results of the 2026 Annual General Meeting	EQ
12/05	Darwin AG publishes financial figures and provides business update for 2025	EQ
09/04	Darwin AG to Present at Invest 2026 in Stuttgart and the Equity Forum in Frankfurt	EQ
18/03	Darwin AG launches commercialization of Multi-Cancer Check — a blood test for early detection of 13 types of cancer	EQ
25/02	Darwin AG Announces Preliminary Group Revenue for 2025 and Confirms Strategic Growth Trajectory	EQ
05/02	RESEARCH: ODDO BHF Initial Coverage 23.01.2026	PU
26/01	RESEARCH: ODDO BHF Initial Coverage 23.01.2026	PU
05/12	Darwin : Corporate News Q3 results	PU
24/11	Darwin : Corporate News Sales Partnership Hartlauer	PU
10/11	Darwin : Corporate News Partnership	PU
21/10/25	Darwin : Corporate News Medical Genetics	PU
18/09/25	Darwin : Implementation Stock Split	PU
12/02/25	Darwin : Turnover 2024 Outlook 2025	PU
19/12/24	Darwin : AD-HOC Announcement Acquisition MEDICOPHARM	PU
19/12/24	Darwin : Acquisition MEDICOPHARM	PU
15/10/24	Darwin : publishes issuer report for the first half of 2024	PU